Sitemap
September 28, 2009 Articles
Filter by Available Specialty
- Bausch & Lomb, Croma Pharma to co-promote bromfenac in some European markets
- Carefully choose glaucoma therapy for patients with financial issues
- Deficits in grey brain matter found in children with congenital hypothyroidism
- Efficacy, cost-effectiveness data favor new antiplatelets over clopidogrel in patients with ACS
- FDA approves pralatrexate for peripheral T-cell lymphoma
- FDA issues early communication about safety review of deferasirox
- FDA premarket approval process of medical devices to be reviewed
- FDA premarket approval process of medical devices to be reviewed
- High-dose daunorubicin during induction therapy safe, effective for AML
- Intracorneal inlay improves near vision in presbyopic patients
- Investigators find way to halt excessive bone growth following trauma or surgery
- Laser enhancement after IOL implantation effective, but not for all patients
- Monovision can provide good near acuity for motivated LASIK patients
- Premium IOL surgery presents great challenge, opportunity
- SPIRIT IV: Everolimus-eluting stent trumped paclitaxel-eluting stent, but not in patients with diabetes
- The MTV public service announcement on breast cancer: Is it appropriate?
- Will we run out of ophthalmologists?